Shanghai Runda Medical Technology Co., Ltd. delivers comprehensive medical laboratory solutions throughout China. The company furnishes a suite of offerings including platform deployment, laboratory layout and modernization, adherence to standardization protocols, and sophisticated information management systems. They also provide medical diagnostic tools for professionals across areas such as biochemistry, diabetes management, point-of-care testing, immunoassay analysis, and molecular biology. Complementing these are specialized technical assistance and efficient logistical support. Established in 1999, the firm maintains its principal operations in Shanghai, China, and has expanded its footprint to include over 50 subsidiaries, providing integrated services to more than 4,000 public medical institutions. Notably, in 2022, the company formed a joint venture with QuidelOrtho to develop and manufacture assays for the VITROS® platform within China, further enhancing its in-vitro diagnostics capabilities.